title: Calcium acetate, an effective phosphorus binder in patients with renal failure.
abstract: Calcium salts are increasingly used as phosphorus binders in patients with chronic renal failure. Calcium carbonate is the principal salt presently utilized, however, other calcium salts may be more effective and safer phosphorus binders. Theoretical calculations, in vitro experiments, and in vivo studies in normal subjects have shown calcium acetate to be a more effective phosphorus binder than other calcium salts. This salt has not previously been studied in patients with chronic renal failure. We used a one-meal gastrointestinal balance technique to measure phosphorus absorption, calcium absorption and phosphorus binding in six patients with chronic renal failure. Calcium acetate was compared with calcium carbonate and placebo. Equivalent doses (50 mEq Ca++) of calcium acetate bound more than twice as much phosphorus (106 +/- 23 mg) as calcium carbonate (43 +/- 39 mg) P less than 0.05. When phosphorus binding was factored for calcium absorption, calcium acetate bound 0.44 mEq HPO4 =/mEq absorbed Ca++ compared with 0.16 mEq HPO4 = bound/mEq Ca++ absorbed with calcium carbonate. More efficient phosphorus binding permits serum phosphorus concentration to be controlled with lower doses of calcium salts. The higher phosphorus binding/calcium absorption ratio coupled with a lower dose indicates that less calcium will be absorbed when calcium acetate is used for phosphorus control. Markedly positive calcium balance, hypercalcemia and ectopic calcification should be less likely to occur with this drug than other calcium salts.
authors: Baylor University Medical Center, Dallas, Texas.
authors: M L
authors: ML
authors: Mai
authors: M
authors: M
authors: Emmett
authors: M S
authors: MS
authors: Sheikh
authors: C A
authors: CA
authors: Santa Ana
authors: L
authors: L
authors: Schiller
authors: J S
authors: JS
authors: Fordtran
mesh_terms: D000085:Acetates / Q000627:therapeutic use*; D019342:Acetic Acid; D000328:Adult; D002119:Calcium Carbonate / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007408:Intestinal Absorption / Q000187:drug effects; D007676:Kidney Failure, Chronic / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D010758:Phosphorus / Q000378:metabolism*; D006435:Renal Dialysis
chemical_list: D000085:Acetates; D010758:Phosphorus; D002119:Calcium Carbonate; D019342:Acetic Acid